Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16292 studies found for:    PLCB4
Show Display Options
Rank Status Study
1 Completed Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
Condition: HIV-1 Infection
Interventions: Drug: Part A: lenalidomide dose escalation;   Drug: Part B: lenalidomide;   Drug: Part B: lenalidomide placebo
2 Completed A Phase 2 Study of the Effects of 6R-BH4 on Symptomatic Peripheral Arterial Disease
Condition: Intermittent Claudication
Interventions: Drug: Placebo for 6R-BH4 (sapropterin dihydrochloride);   Drug: 6R-BH4 (sapropterin dihydrochloride)
3 Completed
Has Results
Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)
Conditions: Anesthesia;   Neuromuscular Blockade
Interventions: Drug: Sugammadex;   Drug: 0.9% sodium chloride (NaCl)
4 Completed Comparison of Synera Patch Versus LMX-4 Cream Versus Placebo Patch for Pain Reduction During Venipuncture in Children
Conditions: Pain;   Venipuncture;   Anesthetics, Local
Interventions: Drug: Synera Patch;   Drug: LMX 4 Cream;   Drug: Placebo Patch
5 Completed T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
Conditions: Actinic Keratosis;   Basal Cell Carcinoma of the Skin;   Recurrent Skin Cancer;   Squamous Cell Carcinoma of the Skin
Interventions: Drug: liposomal T4N5 lotion;   Other: placebo;   Other: laboratory biomarker analysis
6 Not yet recruiting A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Conditions: Overactive Bladder;   Mild Cognitive Impairment
Interventions: Drug: fesoterodine 4mg;   Drug: Oxybutynin;   Drug: placebo;   Drug: fesoterodine 8mg
7 Active, not recruiting A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: HS-25;   Drug: Placebo
8 Active, not recruiting Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
Condition: BPH
Interventions: Drug: dutasteride 0.5 mg, used with tolterodine ER 4mg or placebo;   Drug: dutasteride
9 Completed
Has Results
Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Hyper-immune Bovine Colostrum;   Other: raltegravir placebo;   Other: Hyper-immune Bovine Colostrum placebo;   Drug: raltegravir and hyper-immune bovine colostrum
10 Completed LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery
Condition: Post-Operative Pain
Interventions: Drug: LMX4;   Drug: LMX4 Placebo
11 Active, not recruiting Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Conditions: Lambert-Eaton Myasthenic Syndrome;   Eaton-Lambert Myasthenic Syndrome
Interventions: Drug: 3,4-DAP;   Drug: 3,4-DAP Taper to Placebo
12 Completed A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
Condition: Symptomatic Gastroesophageal Reflux Disease (sGERD)
Interventions: Drug: Esomeprazole;   Drug: Matching placebo
13 Completed
Has Results
Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain
Condition: Pain
Interventions: Drug: IV Placebo;   Drug: IV Acetaminophen
14 Completed
Has Results
A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber
Conditions: Rhinitis, Allergic, Perennial;   Allergic Rhinitis
Interventions: Drug: Fluticasone propionate;   Drug: Placebo
15 Recruiting Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate (DMF)-Treated Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: dimethyl fumarate;   Drug: Acetylsalicylic acid;   Drug: ASA-Placebo
16 Terminated Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
Condition: Prevention of Growth Restriction
Interventions: Drug: rhBSSL (recombinant human bile-salt-stimulated lipase);   Drug: Placebo
17 Completed
Has Results
Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550;   Drug: Placebo
18 Recruiting Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions
Condition: Dental Caries
Interventions: Device: Curodont Repair;   Other: Placebo;   Device: Fluoride
19 Completed Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
Conditions: Bird Flu;   Influenza
Interventions: Other: Placebo;   Biological: Ad4-H5-Vtn;   Biological: Sanofi Pasteur Influenza Virus Vaccine, H5N1
20 Completed
Has Results
Sugammadex Hypersensitivity Study (Study P06042)
Condition: Hypersensitivity
Interventions: Drug: Placebo run-in dose;   Drug: Sugammadex 4 mg/kg;   Drug: Sugammadex 16 mg/kg;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years